NEW YORK, April 8, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (NASDAQ: OSMT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980….
News You Missed
